Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor. Virol J. 2012 Nov 23; 9:285.
View in:
PubMed
subject areas
Animals
Biological Products
Disease Models, Animal
Enterovirus A, Human
Immunosuppressive Agents
Mice
Mice, Inbred ICR
Neurogenic Inflammation
Receptors, Complement
Receptors, Complement 3b
Receptors, Complement 3d
Recombinant Fusion Proteins
Treatment Outcome
authors with profiles
Stephen Tomlinson
Carl Atkinson